Delta-6-desaturase Links Polyunsaturated Fatty Acid Metabolism With Phospholipid Remodeling and Disease Progression in Heart Failure
暂无分享,去创建一个
R. Murphy | S. Zarini | G. Bouma | M. Bristow | J. M. Lynch | Catherine H. Le | C. Mulligan | Melissa A. Routh | M. Frye | K. Jeckel | G. Sparagna | Russell L. Moore | S. Mccune | A. Chicco | R. Moore | Melinda A. Frye
[1] G. Hatch,et al. Dietary linoleate preserves cardiolipin and attenuates mitochondrial dysfunction in the failing rat heart. , 2012, Cardiovascular research.
[2] C. Koehler,et al. The complexity of cardiolipin in health and disease. , 2012, Trends in biochemical sciences.
[3] L. Kirshenbaum,et al. Multiple facets of NF-κB in the heart: to be or not to NF-κB. , 2011, Circulation Research.
[4] S. Prabhu,et al. Cardiomyocyte NF-κB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure. , 2011, Cardiovascular research.
[5] D. Graham,et al. Cyclooxygenase and thromboxane/prostaglandin receptor contribute to aortic endothelium-dependent dysfunction in aging female spontaneously hypertensive rats. , 2009, Journal of applied physiology.
[6] G. Hatch,et al. Cardiolipin biosynthesis and remodeling enzymes are altered during development of heart failure , 2009, Journal of Lipid Research.
[7] H. Aburatani,et al. Cardiac 12/15 lipoxygenase–induced inflammation is involved in heart failure , 2009, The Journal of experimental medicine.
[8] R. Murphy,et al. Transcellular biosynthesis of cysteinyl leukotrienes in vivo during mouse peritoneal inflammation , 2009, Proceedings of the National Academy of Sciences.
[9] M. Schlame,et al. Formation of molecular species of mitochondrial cardiolipin. 1. A novel transacylation mechanism to shuttle fatty acids between sn-1 and sn-2 positions of multiple phospholipid species. , 2009, Biochimica et biophysica acta.
[10] Takao Shimizu,et al. Acyl-CoA:Lysophospholipid Acyltransferases* , 2009, Journal of Biological Chemistry.
[11] R. Gross,et al. Eicosanoid signalling pathways in the heart. , 2008, Cardiovascular research.
[12] Thomas Illig,et al. FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. , 2008, The American journal of clinical nutrition.
[13] J. Sundström,et al. Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study. , 2008, The American journal of clinical nutrition.
[14] Thomas D. Schmittgen,et al. Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.
[15] S. Neubauer,et al. Increased mitochondrial uncoupling proteins, respiratory uncoupling and decreased efficiency in the chronically infarcted rat heart. , 2008, Journal of molecular and cellular cardiology.
[16] R. Murphy,et al. Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure Published, JLR Papers in Press, April 10, 2007. , 2007, Journal of Lipid Research.
[17] Xianlin Han,et al. Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipidomics study. , 2007, Biochemistry.
[18] T. Ueland,et al. Role of inflammation in the progression of heart failure , 2007, Current cardiology reports.
[19] Stefan Neubauer,et al. The failing heart--an engine out of fuel. , 2007, The New England journal of medicine.
[20] K. Duffin,et al. Novel, selective Δ6 or Δ5 fatty acid desaturase inhibitors as antiinflammatory agents in mice , 2007, Lipids.
[21] G. Sparagna,et al. Role of cardiolipin alterations in mitochondrial dysfunction and disease. , 2007, American journal of physiology. Cell physiology.
[22] S. Rapoport,et al. Lipids in Health and Disease , 2006 .
[23] W. Paulus,et al. Myocardial cytokine gene expression is higher in aortic stenosis than in idiopathic dilated cardiomyopathy , 2005, Heart.
[24] R. Murphy,et al. Quantitation of cardiolipin molecular species in spontaneously hypertensive heart failure rats using electrospray ionization mass spectrometry Published, JLR Papers in Press, March 16, 2005. DOI 10.1194/jlr.M500031-JLR200 , 2005, Journal of Lipid Research.
[25] Manabu T. Nakamura,et al. STRUCTURE, FUNCTION, AND DIETARY REGULATION OF Δ6, Δ5, AND Δ9 DESATURASES , 2004 .
[26] C. Leslie. Regulation of arachidonic acid availability for eicosanoid production. , 2004, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[27] Manabu T. Nakamura,et al. Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. , 2004, Annual review of nutrition.
[28] A. Sanbe,et al. Changes in fatty acid compositions of myocardial lipids in rats with heart failure following myocardial infarction , 2004, Molecular and Cellular Biochemistry.
[29] M. Sutton,et al. COX-2–Dependent Cardiac Failure in Gh/tTG Transgenic Mice , 2003, Circulation research.
[30] J. Nadler,et al. Overexpression of 12-lipoxygenase and cardiac fibroblast hypertrophy. , 2003, Trends in cardiovascular medicine.
[31] E. Blasi,et al. Structural, functional, and molecular characterization of the SHHF model of heart failure. , 2002, American journal of physiology. Heart and circulatory physiology.
[32] D. Burkhoff,et al. Disease-specific remodeling of cardiac mitochondria after a left ventricular assist device. , 2002, The Annals of thoracic surgery.
[33] J. Masferrer,et al. Selective inhibition of Delta-6 desaturase impedes intestinal tumorigenesis. , 2002, Cancer letters.
[34] K. Duffin,et al. Lipid remodeling in mouse liver and plasma resulting from Δ6 fatty acid desaturase inhibition , 2001, Lipids.
[35] J. McHowat,et al. Redistribution and abnormal activity of phospholipase A(2) isoenzymes in postinfarct congestive heart failure. , 2001, American journal of physiology. Cell physiology.
[36] G. Poli,et al. 4‐Hydroxynonenal in the Pathomechanisms of Oxidative Stress , 2000, IUBMB life.
[37] P. Kang,et al. Apoptosis and heart failure: A critical review of the literature. , 2000, Circulation research.
[38] M. Portero-Otín,et al. Double bond content of phospholipids and lipid peroxidation negatively correlate with maximum longevity in the heart of mammals , 2000, Mechanisms of Ageing and Development.
[39] A. Folsom,et al. Plasma fatty acid composition and 6-year incidence of hypertension in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. , 1999, American journal of epidemiology.
[40] K. Duffin,et al. Novel, selective delta6 or delta5 fatty acid desaturase inhibitors as antiinflammatory agents in mice. , 1999, Lipids.
[41] G. FitzGerald,et al. Prostaglandin F2α (PGF2α) and the Isoprostane, 8,12-iso-Isoprostane F2α-III, Induce Cardiomyocyte Hypertrophy , 1998, The Journal of Biological Chemistry.
[42] I. Rodger,et al. Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure. , 1998, Circulation.
[43] A. Omran,et al. Increased oxidative stress in patients with congestive heart failure. , 1998, Journal of the American College of Cardiology.
[44] G. FitzGerald,et al. Prostaglandin F2alpha (PGF2alpha) and the isoprostane, 8, 12-iso-isoprostane F2alpha-III, induce cardiomyocyte hypertrophy. Differential activation of downstream signaling pathways. , 1998, The Journal of biological chemistry.
[45] M. Karin,et al. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.
[46] D. Girelli,et al. Increased membrane ratios of metabolite to precursor fatty acid in essential hypertension. , 1997, Hypertension.
[47] P. Singal,et al. Role of oxidative stress in transition of hypertrophy to heart failure. , 1996, Journal of the American College of Cardiology.
[48] R. Vasan,et al. The progression from hypertension to congestive heart failure. , 1996, JAMA.
[49] H. Esterbauer,et al. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.
[50] B. O’Rourke,et al. Altered phospholipid metabolism in pressure-overload hypertrophied hearts. , 1986, The American journal of physiology.
[51] G. Summer,et al. Improved method for hydroxyproline analysis in tissue hydrolyzates. , 1971, Analytical biochemistry.